The problem of quality of medications at Russian market (1992–2004). Report I. The control systems

The archives of Ministry of Health of Russia, journal publications, interviews and memoirs testify that issue of quality of medications was key one in life of Russian Pharma in 1992-2004. The drug safety support considered not only as part of social policy, but also as rules that could be used to reformat"wild bazaar" into "controlled market". The media disputes, departmental justifications, political bills and memoirs give idea about "price of the issue" - tension of emotions, ambitions, financial losses. Furthermore, depending on one who would determine quality (therefore evaluate all players in Pharma market) depended where center of power would be located in the market. In series of reports results of historical reconstruction of building materials, architects and technologies of Russian regulatory system and market rules are presented. The first report considers differences in modes of resolving problems of quality of medications in so-called "socialist" and "capitalist" worlds. Accordingly, what kind of controlling infrastructure inherited modernized Russian state from the USSR is demonstrated. The efforts of Ministry of Health of Russia to preserve and to strengthen this inheritance are presented as struggle for impacting market in conditions of resource-deficient space.